Evidence based research on market structure, competitive dynamics, and strategic implications. Our intelligence is designed to support decision makers evaluating market opportunities, competitive positioning, and investment decisions.
The voluntary carbon market is forecast to grow from US$1.4B in 2024 to US$22B by 2032 (40% CAGR), driven by ICVCM CCP integrity-tier convergence, CORSIA Phase 2 from 2027, and Big Tech CDR offtake.
The global grid-scale BESS market grows from US$13 billion in 2024 to US$135 billion by 2032 at 33% CAGR, anchored by ERCOT 14 GW, CAISO 17 GW, Tesla and Sungrow leadership, and IRA 45X battery cell credit.
The global SMR market grows from US$2.5 billion in 2024 to US$40 billion by 2035 at 30% CAGR, anchored by Microsoft-TMI restart, Amazon-X-energy, Google-Kairos PPAs, TerraPower Wyoming, and AI-data-centre power demand.
The global green hydrogen market is forecast to grow from US$8 billion in 2024 to US$70 billion by 2032 at 31% CAGR, anchored by NEOM 2027 startup, IRA 45V final rules, and EU REPowerEU 10 Mt domestic and 10 Mt import targets for 2030.
The global precision oncology diagnostics market grows from US$24 billion in 2024 to US$65 billion by 2032 at 13% CAGR, driven by NGS expansion, MRD adoption (Signatera up 52% in volume), and Tempus AI's US$1.3 billion 2025 revenue.
Global hospital-at-home is forecast to grow from US$5 billion in 2024 to US$35 billion by 2032 at 28% CAGR, anchored by the CMS waiver extension to September 2030 and 419 approved US hospitals.
The global cell and gene therapy CDMO market grows from US$7 billion in 2024 to US$50 billion by 2032 at 28% CAGR, driven by more than 30 approved CGTs, BIOSECURE-induced decoupling, and Novo Holdings-Catalent reshaping capacity.
Beyond published intelligence
We provide custom research for specific strategic questions. Explore our capabilities or review sector coverage.